CONCENTRA GROUP HOLDINGS PARENT, INC.

CON ·Healthcare, Medical Care Facilities, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022
Revenue $2.16B $1.90B $1.84B $1.72B
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $203.3M $156.3M $152.0M $150.0M
Operating Income $334.0M $304.8M $287.6M $258.5M
Operating Margin 15.4% 16.0% 15.6% 15.0%
Interest Expense
Pretax Income $223.8M $231.4M $242.6M $224.9M
Income Tax Expense $51.0M $59.5M $57.9M $52.7M
Net Income $166.4M $166.5M $179.9M $166.7M
Net Margin 7.7% 8.8% 9.8% 9.7%
EPS (Basic) $1.30 $1.46 $1.73 $1.60
EPS (Diluted) $1.30 $1.46 $1.73 $1.60
Shares Outstanding (Basic) 128.6M 126.6M 114.1M 104.0M 103.8M
Shares Outstanding (Diluted) 128.6M 128.3M 114.2M 104.2M 103.8M
Dividends Per Share $0.25 $0.06